SARTORIUS STED BIO (EPA:DIM) | WebDisclosure

Basculer en Français

10606	Companies
225110	Keywords
153808	Articles
119119	Press releases

Home
Companies
SARTORIUS STED BIO

PRESS RELEASE

published on 07/18/2024 at 18:21, 1 year 11 months ago

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Sartorius Stedim Biotech adjusts fiscal year 2024 guidance with positive sales trend in H1 2024 amid volatile market. Company's key financials and outlook disclosed

Fiscal Year 2024 Sartorius Stedim Biotech Outlook Sales Trend Key Financial Indicators
PRESS RELEASE

published on 07/18/2024 at 18:21, 1 year 11 months ago

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech ajuste ses prévisions pour l’exercice 2024 et présente ses résultats pur le premier semestre 2024
Sartorius Stedim Biotech ajuste ses prévisions pour l'exercice 2024 et présente ses résultats pour le premier semestre. L'entreprise termine la première moitié de l'exercice avec une évolution positive du chiffre d'affaires malgré les défis du marché des sciences de la vie

Chiffre D'affaires Sartorius Stedim Biotech Prévisions 2024 Sciences De La Vie Résultats Premier Semestre
BRIEF

published on 07/02/2024 at 14:58, 1 year 11 months ago

Nombre d'actions et de droits de vote de Sartorius Stedim Biotech SA

Droits De Vote Capital Social Actions AMF Sartorius Stedim Biotech
BRIEF

published on 07/02/2024 at 14:58, 1 year 11 months ago

Number of shares and voting rights of Sartorius Stedim Biotech SA

Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
PRESS RELEASE

published on 07/02/2024 at 14:53, 1 year 11 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL
Déclaration de Sartorius Stedim Biotech SA concernant le nombre d'actions et de droits de vote du capital social. Communiqué réglementaire

Déclaration Droits De Vote Capital Social Actions Sartorius Stedim Biotech SA
PRESS RELEASE

published on 07/02/2024 at 14:53, 1 year 11 months ago

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA declares number of shares and voting rights in the issued capital according to French regulations. Details in press release

Voting Rights Shares French Regulations Sartorius Stedim Biotech SA Issued Capital
BRIEF

published on 07/02/2024 at 11:30, 1 year 11 months ago

Bilan semestriel du contrat de liquidité de Sartorius Stedim Biotech

Kepler Cheuvreux Liquidité AMF Sartorius Transparence
BRIEF

published on 07/02/2024 at 11:30, 1 year 11 months ago

Half-year review of the Sartorius Stedim Biotech liquidity contract

Liquidity Kepler Cheuvreux AMF Transparency Sartorius
PRESS RELEASE

published on 07/02/2024 at 11:27, 1 year 11 months ago

Sartorius Stedim Biotech SA: Bilan semestriel du contrat de liquidité de la société Sartorius Stedim Biotech
Publication du bilan semestriel du contrat de liquidité de Sartorius Stedim Biotech S.A. avec Kepler Cheuvreux. Respect des pratiques de marché admises selon la décision AMF n°2021-01

Contrat De Liquidité Bilan Semestriel Kepler Cheuvreux AMF Sartorius Stedim Biotech
PRESS RELEASE

published on 07/02/2024 at 11:27, 1 year 11 months ago

Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech's half-year liquidity contract statement reveals significant shares and volume on June 30th, 2024. The company is a key player in the biopharmaceutical industry with a global presence

Liquidity Contract Shares Traded Volume Sartorius Stedim Biotech Biopharmaceutical Industry

Accesswire

Published on 06/22/2026 at 11:00, 22 minutes ago

American Critical Minerals Mobilizes to the Green River Project to Commence Drill Pad Construction
Published on 06/22/2026 at 09:01, 2 hours 21 minutes ago

Apex Drills 14.9 m of 5.09 % REO and 12.3 m of 5.63 % REO with > 2.50 % REO Intercept Over 191.9 m in the Trinity Zone at the Rift Rare Earth Project
Published on 06/22/2026 at 03:00, 8 hours 22 minutes ago

Tunkillia Pre-Feasibility Study Begins
Published on 06/20/2026 at 01:00, 2 days 10 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 11 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 11:12, 9 minutes ago

POS-Transaction in Own Shares
Published on 06/22/2026 at 11:05, 17 minutes ago

Hisense Showcases "Innovating a Brighter Life" Message at FIFA World Cup 2026™
Published on 06/22/2026 at 11:02, 19 minutes ago

Siltronic returns to the MDAX
Published on 06/22/2026 at 11:00, 22 minutes ago

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Published on 06/22/2026 at 10:55, 27 minutes ago

Envision Energy Unveils 2026 Net Zero Action Report at VivaTech, Pioneering Future Energy Systems for Civilizational Prosperity

Les Echos

Published on 06/22/2026 at 08:30, 2 hours 52 minutes ago

Eiffage entre en négociation exclusive avec Atlas Arteria en vue d’acquérir la concession du tunnel de Warnow à Rostock, en Allemagne
Published on 06/22/2026 at 08:30, 2 hours 52 minutes ago

Eiffage enters into exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
Published on 06/19/2026 at 19:33, 2 days 15 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 15 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 15 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026

View all LES ECHOS COMFI WIRE